| Q37155662 | 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure |
| Q92808641 | 6-minute walking test: a useful tool in the management of heart failure patients |
| Q33748526 | 6MWT Performance and its Correlations with VO₂ and Handgrip Strength in Home-Dwelling Mid-Aged and Older Chinese |
| Q35185405 | A Cardiopulmonary Instructor's Perspective on a Standardized Patient Experience: Implications for Cardiopulmonary Physical Therapy Education |
| Q51202602 | ASC Methylation and Interleukin-1β Are Associated with Aerobic Capacity in Heart Failure. |
| Q39619466 | Assessment of human ambulatory speed by measuring near-body air flow |
| Q35799782 | Association Between 6-Minute Walk Test and All-Cause Mortality, Coronary Heart Disease-Specific Mortality, and Incident Coronary Heart Disease |
| Q39840523 | Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure |
| Q53194504 | Association of soluble ST2 with functional capacity in outpatients with heart failure. |
| Q35366259 | Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol |
| Q84927373 | Bradypedia: is gait speed ready for clinical use? |
| Q33721665 | Can exercise capacity assessed by the 6 minute walk test predict the development of major adverse cardiac events in patients with STEMI after fibrinolysis? |
| Q37252858 | Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary |
| Q35743713 | Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life |
| Q88711793 | Chronic Heart Failure Care Planning: Considerations in Older Patients |
| Q37116409 | Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure |
| Q42601517 | Clinically significant improved fitness and weight loss among overweight persons with serious mental illness |
| Q36462172 | Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial |
| Q37193803 | Cognitive reserve moderates the association between heart failure and cognitive impairment |
| Q34084220 | Combined aerobic and resistance exercise program improves task performance in patients with heart failure |
| Q37433582 | Comparison of predictors of heart failure-related hospitalization or death in patients with versus without preserved left ventricular ejection fraction |
| Q33574597 | Comparison of walking performance over the first 2 minutes and the full 6 minutes of the Six-Minute Walk Test |
| Q33511919 | Continuous, non-invasive measurement of the haemodynamic response to submaximal exercise in patients with diabetes mellitus: evidence of impaired cardiac reserve and peripheral vascular response. |
| Q35032815 | Contributions of Comorbid Diabetes to Sleep Characteristics, Daytime Symptoms, and Physical Function Among Patients With Stable Heart Failure |
| Q36047597 | Correlation between impedance cardiography and 6 min walk distance in atrial fibrillation patients |
| Q48398010 | Correlation of B-type natriuretic peptide level to 6-min walk test performance in patients with left ventricular systolic dysfunction |
| Q35347215 | DIFFERENCES IN EXERCISE PERFORMANCE AND LEISURE-TIME PHYSICAL ACTIVITY IN OLDER CAUCASIANS AND AFRICAN-AMERICANS |
| Q36922049 | DIFFERENCES IN EXERCISE PERFORMANCE AND LEISURE-TIME PHYSICAL ACTIVITY IN OLDER MEN AND WOMEN |
| Q37255058 | Depressive symptomatology, exercise adherence, and fitness are associated with reduced cognitive performance in heart failure |
| Q48283568 | Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials? |
| Q30842767 | Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations |
| Q33814148 | Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis |
| Q37371550 | Diastolic function is associated with quality of life and exercise capacity in stable heart failure patients with reduced ejection fraction |
| Q37255063 | Dietary habits moderate the association between heart failure and cognitive impairment. |
| Q33603737 | Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve? |
| Q90473887 | Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series Analysis |
| Q36833645 | Educational needs for improving self-care in heart failure patients with diabetes |
| Q40489029 | Estimated Glomerular Filtration Rate and 6-Minute Walk Distance in African Americans with Mild to Moderate Heart Failure |
| Q36876787 | Evaluation of frailty in older adults with cardiovascular disease: incorporating physical performance measures |
| Q36768204 | Evidence-based approach to exercise prescription in chronic heart failure. |
| Q39180182 | Exercise Capacity, Heart Failure Risk, and Mortality in Older Adults: The Health ABC Study |
| Q34022098 | Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). |
| Q43473201 | Exercise capacity is the most powerful predictor of 2-year mortality in patients with left ventricular systolic dysfunction |
| Q39090266 | Exercise capacity, physical activity, and morbidity. |
| Q41381394 | Exercise for patients with congestive heart failure |
| Q37077445 | Exercise performance, physical activity, and health-related quality of life in participants with stable angina |
| Q33654859 | Exercise testing in assessment and management of patients in clinical practice - present situation |
| Q36574995 | Exercise testing with concurrent beta-blocker usage: is it useful? What do we learn? |
| Q90101731 | Factors affecting hospital readmission heart failure patients in Japan: a multicenter retrospective cohort study |
| Q77353810 | Factors influencing exercise performance in patients with left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction |
| Q37435176 | Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure |
| Q41864375 | Feasibility of Behavioral Weight Loss Treatment Enhanced with Peer Support and Mobile Health Technology for Individuals with Serious Mental Illness |
| Q37351995 | Frailty and risk for heart failure in older adults: the health, aging, and body composition study |
| Q33806102 | From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension |
| Q37104436 | Functional outcomes for clinical trials in frail older persons: time to be moving |
| Q81744409 | Haemodynamic effects of dual-chamber pacing versus ventricular pacing during a walk test in patients with depressed or normal left ventricular function |
| Q37368702 | Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial |
| Q84478579 | Heart failure |
| Q84857476 | Heart failure |
| Q34190471 | Heart failure: Part I. First hospitalization and post-hospital care |
| Q36451082 | Heart rate response to a timed walk and cardiovascular outcomes in older adults: the cardiovascular health study. |
| Q34881800 | Impact of concomitant aortic regurgitation on long-term outcome after surgical aortic valve replacement in patients with severe aortic stenosis |
| Q35761017 | Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults ≥65 years with heart failure. |
| Q36697559 | Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure |
| Q92165320 | Left Ventricular Flow Analysis |
| Q64998433 | Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction. |
| Q36316521 | Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes |
| Q36419803 | Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats. |
| Q34666793 | Maximal fitness testing in sedentary elderly at substantial risk of disability: LIFE-P study experience |
| Q73372160 | Measurement of Cardiac Functioning in Older Adults With Heart Failure After Exercise |
| Q36885431 | Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure |
| Q38820447 | Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome |
| Q33506869 | N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study |
| Q34009129 | NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa |
| Q34494866 | Noninvasive ventilation and exercise tolerance in heart failure: A systematic review and meta-analysis |
| Q39464706 | Objective assessment of the response to treatment of severe heart failure using a 9-minute walk test on a patient-powered treadmill |
| Q33588410 | Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure |
| Q36859454 | Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease |
| Q46411414 | Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase |
| Q35370589 | Oxygen uptake kinetics during low level exercise in patients with heart failure: relation to neurohormones, peak oxygen consumption, and clinical findings |
| Q36709180 | Pathophysiological effects of different risk factors for heart failure |
| Q37637856 | Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. |
| Q37025044 | Physical health status measures predict all-cause mortality in patients with heart failure |
| Q24288983 | Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes |
| Q87620229 | Predicting prognosis based on the shape of the left ventricular cavity in dilated cardiomyopathy: analysis using rate of improvement in the circle index |
| Q36806963 | Predicting survival in heart failure |
| Q37167810 | Prediction of mortality in patients with heart failure and systolic dysfunction |
| Q90135788 | Predictive factors for ambulatory state in critical limb ischemia patients at discharge |
| Q90147478 | Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study |
| Q35846621 | Prognostic value of 6-minute walk test in stable outpatients with heart failure |
| Q48742297 | Prognostic value of preprocedural 6-min walk test in patients undergoing transcatheter mitral valve repair-insights from the German transcatheter mitral valve interventions registry |
| Q36017245 | Prognostic value of the six-minute walk test in end-stage renal disease life expectancy: a prospective cohort study. |
| Q37091125 | Prognostic value of the six-minute walk test in heart failure patients undergoing cardiac surgery: a literature review |
| Q34490587 | Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure |
| Q33920259 | Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation |
| Q37268886 | Quality of life in a diverse population of patients with heart failure: BASELINE FINDINGS FROM THE HEART FAILURE ADHERENCE AND RETENTION TRIAL (HART). |
| Q42682335 | Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF. |
| Q48601092 | Quantifying and Reducing Motion Artifacts in Wearable Seismocardiogram Measurements During Walking to Assess Left Ventricular Health |
| Q36011388 | Randomized clinical trial of an integrated self-care intervention for persons with heart failure and diabetes: quality of life and physical functioning outcomes |
| Q57822514 | Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure |
| Q85089668 | Rehabilitation and 6-minute walk test after liver transplantation |
| Q34669222 | Relationship between exercise induced dyspnea and functional capacity with doppler-derived diastolic function'. |
| Q35673587 | Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure |
| Q35369043 | Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients |
| Q37147368 | Reproducibility of the self-controlled six-minute walking test in heart failure patients. |
| Q47419512 | Sex-, age-, and height-specific reference curves for the 6-min walk test in healthy children and adolescents |
| Q34136778 | Six minute walk test in people with tuberculosis sequelae |
| Q37094605 | Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure |
| Q37732432 | Six-Minute Walk Test Vs. Three-Minute Step Test for Measuring Functional Endurance |
| Q37707309 | Six-Minute Walk Test as a Predictor for Outcome in Children with Dilated Cardiomyopathy and Chronic Stable Heart Failure |
| Q36721854 | Six-Minute Walking Test: Normal Reference Values for Taiwanese Children and Adolescents |
| Q52659263 | Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy. |
| Q34308313 | Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study |
| Q34795164 | Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors |
| Q38596709 | Skeletal Muscle Changes in Chronic Cardiac Disease and Failure. |
| Q26771791 | Spatiotemporal Changes Posttreatment in Peripheral Arterial Disease |
| Q80306366 | Submaximal effort tolerance as a predictor of all-cause mortality in patients undergoing cardiac rehabilitation |
| Q90292247 | Telerehabilitation with live-feed biomedical sensor signals for patients with heart failure: a pilot study |
| Q37255417 | The 2-minute step test is independently associated with cognitive function in older adults with heart failure |
| Q34522378 | The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure. |
| Q36721052 | The Heart Failure Adherence and Retention Trial (HART): design and rationale |
| Q36021612 | The additive effects of type-2 diabetes on cognitive function in older adults with heart failure. |
| Q37328786 | The advancing field of cell-based therapy: insights and lessons from clinical trials. |
| Q36829061 | The influence of systematic pulse-limited physical exercise on the parameters of the cardiovascular system in patients over 65 years of age |
| Q37164664 | The interactive effects of cerebral perfusion and depression on cognitive function in older adults with heart failure. |
| Q37700468 | The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. |
| Q34532871 | The need for palliative care in the management of heart failure |
| Q35105833 | The prognostic significance of renal dysfunction in patients with chronic systolic heart failure |
| Q21132415 | The relationship of walking intensity to total and cause-specific mortality. Results from the National Walkers' Health Study |
| Q33823518 | The role of exercise testing in the evaluation and management of heart failure |
| Q36773692 | Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure |
| Q37227536 | Use of Six-Minute Walk Test to Measure Functional Capacity After Liver Transplantation |
| Q36409120 | Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival |
| Q34321203 | Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status. |
| Q37401864 | What is treatment success in cardiac resynchronization therapy? |
| Q37515580 | Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study |
| Q95429620 | [Aftercare of patients after MitraClip® implantation] |
| Q83106050 | [Functional capacity as a criterion for patient selection--too poor or too good for CRT?] |